Abstract
The aim of this study was to determine the frequency of cutaneous warts (CW) in patients with lupus erythematosus (LE) and evaluate the effect of immunosuppressants on the appearance of CW. Fifty-eight patients with LE, 74 with rheumatoid arthritis (RA), and 105 healthy individuals were interviewed and examined for the presence of CW. All were questioned to find out whether their CW developed before or after onset of the disease or during treatment. Cutaneous warts occurred considerably more often in patients with LE than in healthy control and RA patients (P<0.003 and P<0.04, respectively). The presence of CW did not correlate with the taking of immunosuppressive drugs. The findings suggest that the high prevalence of CW in patients with LE is probably due to defects in some immune mechanisms, independently of immunosuppressive drugs.
Similar content being viewed by others
References
Hahn BH (1997) An overview of the pathogenesis of systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds) Dubois' lupus erythematosus. 5th edn. Williams and Wilkins, Baltimore, pp 69–75
Nagasawa K, Yamauchi Y, Tada Y, Kusaba T, Niho Y, Yoshikawa H (1990) High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. Ann Rheum Dis 49:630–633
Fresco R (1970) Virus-like particles in systemic lupus erythematosus. N Engl J Med 283:1231–1233
Grausz H, Earley LE, Stephens BG, Lee JC, Hopper J Jr (1970) Diagnostic import of virus-like particles in the glomerular endothelium of patients with systemic lupus erythematosus. N Engl J Med 283:506–511
Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Johansson E, Pyrhönen S, Rostila T (1977) Warts and warts virus antibodies in patients with systemic lupus erythematosus. Br Med J 1:74–76
Yell JA, Burge SM (1993) Warts and lupus erythematosus. Lupus 2:21–23
Krizova A, Ouimet J, Goodwin J, Laskin M, Pope J (2002) Systemic lupus erythematosus and infectious triggers: a controlled survey of patients with msk diseases (abstract). J Rheumatol 29:1570
Sterling JC, Kurtz J (1999) Viral infections. In: Champion RH, Burton JL, Burns DA, Breathnach SM (eds) Textbook of dermatology, 6th edn. Blackwell, Oxford, pp 1029–1051
Lowy DR, Androphy EJ (1999) Warts. In: Freedberg IM, Eisen AZ, Wolf K et al (eds) Fitzpatrick's dermatology in general medicine, 5th edn. McGraw-Hill, New York, pp 2484–2497
Morison WL (1975) Viral warts, herpes simplex and herpes zoster in patients with secondary immune deficiency and neoplasms. Br J Dermatol 92:625–630
Bach EA, Kaplan DH, Schreiber RD (1999) Biochemistry, mechanism of action, and biology of the interferon. In: Gallin JI, Snyderman (eds) Inflammation: basic principles and clinical correlates, 3rd edn. Lippincott Williams and Wilkins, Philadelphia, pp 487–503
Horwitz DA, Gray JD, Behrendsen SC, Kubin M, Rengaraju M, Ohtsuka K et al (1998) Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum 41:838–844
Akahoshi M, Nakashima H, Tanaka Y, Kohsaka T, Nagano S, Ohgami E et al (1999) Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum 42:1644–1648
Horwitz DA, Stohl W, Gray JD (1997) T lymphocytes, NK cells, and cytokines in systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds) Dubois' lupus erythematosus, 5th edn. Williams and Wilkins, Baltimore, pp 155–194
Ytterberg SR, Schnitzer TJ (1984) Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon. Ann Rheum Dis 43:457–461
Min DJ, Cho ML, Cho CS, Min SY, Kim WU, Yang SY et al (2001) Decreased production of interleukin-12 and interferon-gamma associated with renal involvement in systemic lupus erythematosus. Scand J Rheumatol 30:159–163
Verthelyi D, Petri M, Ylamus M, Klinman DM (2001) Disassociation of sex hormone levels and cytokine production in SLE patients. Lupus 10:352–358
Tokano Y, Morimoto S, Kaneko H, Amano H, Nozawa K, Takasaki Y, Hashimoto H (1999) Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)-relation to Th1- and Th2-derived cytokines. Clin Exp Immunol 116:169–173
al-Janadi M, al-Balla S, al-Dalaan A, Raziuddin S (1993) Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis and other rheumatic diseases. J Clin Immunol 13:58–67
Morimoto S, Tokano Y, Kaneko H, Nozawa K, Amano H, Hashimoto H (2001) The increased interleukin-13 in patients with systemic lupus erythematosus: relations to other Th1-, Th2-related cytokines and clinical findings. Autoimmunity 34:19–25
Lee JY, Goldman D, Piliero LM, Petri M, Sullivan KE (2001) Interferon-gamma polymorphism in systemic lupus erythematosus. Genes Immunol 2:254–257
Panem S, Irene JC, Henriksen D, Vilcek J (1982) Antibodies to α-interferon in a patient with systemic lupus erythematosus. J Immunol 129:1–3
Lackovic V, Borecky L, Rovensky J, Zitnan D, Lukac J, Matokova M (1984) Periodicity of interferon appearance in serum of patients with systemic lupus erythematosus. Arthritis Rheum 27:597–598
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Korkmaz, C., Ürer, S.M. Cutaneous warts in patients with lupus erythematosus. Rheumatol Int 24, 137–140 (2004). https://doi.org/10.1007/s00296-003-0340-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-003-0340-1